Suppr超能文献

肝素诱导的血小板减少症。

Heparin-induced thrombocytopenia.

作者信息

Szokol Joseph W

机构信息

University of Chicago, Pritzker School of Medicine, Chicago, Illinois, USA.

出版信息

Semin Cardiothorac Vasc Anesth. 2010 Mar;14(1):73-4. doi: 10.1177/1089253210362795.

Abstract

Heparin-induced thrombocytopenia (HIT) is an antibody-mediated reaction caused by exposure to heparin that can lead to devastating thrombotic complications. HIT usually occurs 5 to 10 days after exposure to heparin but can happen more rapidly to patients who are reexposed to heparin within 100 days. The hallmark of this disorder is a sudden drop in platelet count of greater than 50%. Once HIT is suspected the heparin must be immediately discontinued and an anticoagulant (direct thrombin inhibitor or heparinoid) started. For patients presenting for cardiac surgery and cardiopulmonary bypass that have a history of HIT and positive antibodies a direct thrombin inhibitor such as lepirudin, argatroban or bivalirudin must be used in lieu of heparin.

摘要

肝素诱导的血小板减少症(HIT)是一种由接触肝素引起的抗体介导反应,可导致严重的血栓形成并发症。HIT通常在接触肝素后5至10天发生,但对于在100天内再次接触肝素的患者,可能会更快出现。这种疾病的标志是血小板计数突然下降超过50%。一旦怀疑HIT,必须立即停用肝素,并开始使用抗凝剂(直接凝血酶抑制剂或类肝素)。对于有HIT病史且抗体呈阳性的心脏手术和体外循环患者,必须使用直接凝血酶抑制剂,如比伐卢定、阿加曲班或水蛭素,以替代肝素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验